Trigger warnings are widely used in many universities—and increasingly, the wider world. Last year, London's Globe theater attached a trigger warning to Shakespeare's Romeo & Juliet, advising it "contains depictions of ...
Dec 21, 2022
0
7
Researchers at the University of Tokyo have used artificial DNA to target and kill cancer cells in a completely new way. The method was effective in lab tests against human cervical cancer- and breast cancer-derived cells, ...
Dec 21, 2022
0
78
Researchers at Mass Eye and Ear and Northeastern University have discovered a previously unidentified immune response inside the nose that fights off viruses responsible for upper respiratory infections. Further testing has ...
Dec 6, 2022
1
292
Dompé farmaceutici announced new data revealing a novel function of the SARS-CoV-2 spike (S) protein interaction with the human Estrogen Receptor Alpha (ERα) that may lead to the severe coagulopathy observed in patients ...
Nov 30, 2022
0
18
Structural details of an attractive drug target in coronaviruses that could be used against SARS-CoV-2 and in future pandemics have been published today in eLife.
Nov 22, 2022
0
66
The growing list of COVID complications is long and surprising—from brain changes and heart disease to skin rashes and COVID toes.
Oct 13, 2022
0
4
An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new Northwestern Medicine study done in mice.
Oct 5, 2022
0
100
Though well-known as a respiratory illness, COVID-19 can also affect the nervous system, bringing on headaches and fatigue and wiping out the sense of smell. But it's unclear whether these symptoms are caused by an immune ...
Sep 21, 2022
0
17
The 15-valent pneumococcal conjugate vaccine (PCV15) can be used for children aged younger than 19 years, according to recommendations issued by the Advisory Committee on Immunization Practices and published in the Sept. ...
Sep 16, 2022
0
12
A combination of two drugs showed promise in treating relapsed or refractory acute myeloid leukemia (AML) with mutations in the FMS-like tyrosine kinase 3 (FLT3) gene, according to a Northwestern Medicine study published ...
Sep 14, 2022
0
33
